glp-1 receptor agonists for type 2 diabetes in the treatment of e Frontiers | GLP-1 Receptor Agonists:

Uric acid excretion-promoting drugs, with benzbromarone as the core agent, reduce uric acid reabsorption by inhibiting the URAT1 transporter in the renal tubules

Adv Anat Pathol 26:421427

The search terms used were SARS-CoV-2 vaccine, Graves disease, COVID-19 vaccine, Graves disease, hyperthyroidism, COVID-19 vaccine, and hyperthyroidism, SARS-CoV-2 vaccine

The trial participants were at very high risk for subsequent cardiovascular events with 68% having had a heart attack (82% had coronary artery disease) and the rest with prior stroke or peripheral arterial disease or a combination of these entry criteria

Heart disease and stroke statistics-2017 Update: A report from the American heart association

The ATEC measures the effectiveness of autism treatment by assessing communication, social skills, sensory awareness and more